
<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Anaesthesia - Critical Care Blog &#187; Adrenal insufficiency</title>
	<atom:link href="http://hollos.net/category/adrenal-insufficiency/feed/" rel="self" type="application/rss+xml" />
	<link>http://hollos.net</link>
	<description>This is a privately maintained site about anaesthesia and critical care. For more information see About page.</description>
	<lastBuildDate>Tue, 17 Jan 2012 00:50:29 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Etomidate use in severe sepsis and septic shock may contribute to relative adrenal insufficiency but not mortality</title>
		<link>http://hollos.net/2007/08/21/etomidate-use-in-severe-sepsis-and-septic-shock-may-contribute-to-relative-adrenal-insufficiency-but-not-mortality/</link>
		<comments>http://hollos.net/2007/08/21/etomidate-use-in-severe-sepsis-and-septic-shock-may-contribute-to-relative-adrenal-insufficiency-but-not-mortality/#comments</comments>
		<pubDate>Tue, 21 Aug 2007 18:02:03 +0000</pubDate>
		<dc:creator>Laci</dc:creator>
				<category><![CDATA[Adrenal insufficiency]]></category>
		<category><![CDATA[Sepsis]]></category>

		<guid isPermaLink="false">http://theminiblog.co.uk/dad/2007/08/21/etomidate-use-in-severe-sepsis-and-septic-shock-may-contribute-to-relative-adrenal-insufficiency-but-not-mortality/</guid>
		<description><![CDATA[By M Mullen, T Ellis, J Marcelin, V Mangolds, K Przyklenk Acad Emerg Med 2007;14:S187-S188 Introduction Recent literature suggests that etomidate use in severe sepsis/septic shock patients leads to relative adrenal insufficiency. We hypothesize that etomidate does not contribute to adrenal insufficiency or mortality in this opulation. Conclusions Etomidate use may lead to an increase [...]]]></description>
			<content:encoded><![CDATA[<p>By M Mullen, T Ellis, J Marcelin, V Mangolds, K Przyklenk</p>
<p><a title="Direct link to full text" target="_blank" href="http://www.aemj.org/cgi/content/full/14/5_Supplement_1/S187-b">Acad Emerg Med 2007;14:S187-S188</a></p>
<p>Introduction<br />
Recent literature suggests that etomidate use in severe sepsis/septic shock patients leads to relative adrenal insufficiency. We hypothesize that etomidate does not contribute to adrenal insufficiency or mortality in this opulation.</p>
<p>Conclusions<br />
Etomidate use may lead to an increase incidence of adrenal insufficiency in intubated severe sepsis/septic shock patients. However, this risk of adrenal insufficiency was not associated with increased mortality.</p>
]]></content:encoded>
			<wfw:commentRss>http://hollos.net/2007/08/21/etomidate-use-in-severe-sepsis-and-septic-shock-may-contribute-to-relative-adrenal-insufficiency-but-not-mortality/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

